DETERA Therapeutics, a peptide to prevent crescentic glomerulonephritis (CGN)
… Santoro, a graduate of the École Normale Supérieure, who also holds an agrégation in biology and a PhD in immunology. … funding the following month. In June 2025, the start-up was selected by Bpifrance to join the deep tech community. … reduced. This will generate savings for the public health system," says the director. To raise awareness, DETERA …
Published on: